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Despite best available care, uncontrolled chronic kidney disease (CKD) – a 
complex disease that impacts millions in the United States, will eventually progress to 
end stage renal disease which is associated with high morbidity and mortality. New 
evidence suggests management of earlier stages of CKD is effective in delaying disease 
progression. This project evaluated the impact of a CKD class, led by a nephrology nurse 
practitioner, on preventing disease progression in advanced CKD patients with diabetes 
and hypertension. The purpose of the class was to validate the need for the advanced 
practice nurse (APN) in the care continuum of CKD.  CKD education is a quality 
improvement project based on the chronic illness trajectory nursing model by Corbin and 
Strauss. Using a case-control method and a simple descriptive statistic to compare the 
mean values, retrospective data from 52 patients were analyzed.  Twelve non-
participating patients had a mean 7% increase in serum creatinine levels at the 1-year 
mark. Forty participating patients saw a mean decrease of 30% serum creatinine.  With 
significant evidence suggesting  that disease progression is delayed and renal function is 
improved in all study markers for patients who participated in a CKD education class led 
by a nephrology nurse practitioner and who received usual care – an argument can be 
made for updating the APN role in the continuum of  care for those with CKD. The 
results may contribute to social change by providing improved access to quality care that 
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Section 1: Nature of the Project 
 Introduction 
A significant public health problem, chronic kidney disease (CKD) progresses  
rapidly to end stage renal disease (ESRD) without evidence-based management. CKD is 
a term used to characterize a condition of gradual loss of kidney function over time. 
ESRD on the other hand is the final stage of chronic kidney disease when the kidney 
function is below 10 percent of its normal function requiring renal replacement therapy or 
kidney transplant.  Dialysis - a process used for artificial replacement of functions of 
natural kidneys is an expensive life-saving therapy with high rates of complications such 
as infection, anemia, fluid volume overload, cardiovascular diseases and electrolyte 
disorders. Delaying the progress of CKD to ESRD is a goal of Healthy People 2020. 
 An estimated one in ten American adults or more than 20 million people are 
living with some degree of CKD (Leavey, 2012). In 2013, the United States Renal Data 
System (USRDS, 2013) noted a 3.4% growth, or more than 615,000 new cases in ESRD. 
In my local area the Dayton, Ohio Valley area there is about 449 individuals per  million 
with ESRD (Coresh, et al., 2003). According to the American Heart Association (AHA), 
moderate to severe CKD is associated with increased cardiovascular (CVD) disease and 
death since individuals with CKD are five times more likely to die of CVD before 
developing end stage renal disease (Sarnak, et al, 2003). Combating the chronicity and 
delaying the progression of this disease in vulnerable populations can decrease morbidity 
and  mortality (Sarnak, et al, 2003).  
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With the implementation of evidence-based practices for CKD management, the 
progression can be delayed.  The revised clinical guidelines from the National Kidney 
Foundation (NKF) directed clinicians to develop individualized clinical action plans for 
each person with CKD (Inker, 2014). Critics of this original NKF guideline believed that  
recognizing the nephrologist as primary clinician  responsible for CKD patient care 
overlooked the role of nurses, nurse practitioners, dieticians and some ancillary services. 
The American Nephrology Nurses’ Association (ANNA) supports the role of the 
advanced practice nurse (APN) in CKD management in educating and providing quality 
patient care to delay progression of the disease process (2015).   
The introduction of the Patient Protection and Affordable Care Act in March 
2010, commonly referred to as the “Affordable Care Act”  brought  significant changes to 
the access to healthcare services for people with kidney disease by eliminating pre-
existing conditions exclusions. Thus, nephrology practices in the Dayton, Ohio Valley 
area witnessed an influx of new patients with acute kidney injuries and chronic kidney 
diseases (National Kidney Foundation, 2016). This new group of patients hitherto had no 
insurance because they had pre-existing conditions such as diabetes and hypertension that 
require frequent monitoring. The influx of patients has overburdened nephrologists when 
there is already a provider shortage. On average, there are between 65 to 103 patients per 
nephrologist (Harley, 2013).  However, caseload of nephrologist influences her or his 
patients’ outcomes. For example, with each 50 patients increase in caseload, there is an 
associated 2% increase in patient mortality (Harley, 2013).  This reality has prompted the 
Renal Physicians Association (2014) and the American Association of Physician 
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Assistants to call for a joint model of patient care delivery that is cost effective and that 
addresses the complex care required by patients with renal disease. In general, there 
needs to be an increased number of competent clinicians to meet this call.  
Currently for patients with CKD in the Dayton, Ohio area, there is approximately 
a 4 to 8 weeks wait for follow up visits and a 4 to 6 month wait for an appointment when 
referred to the practice. This excessive wait times complicates the care process as good 
clinical management and patient adherence are negatively impacted. The introduction of 
the advanced practice nurse (APN) or nephrology nurse practitioner into this care 
continuum can reduce the wait time from approximately a month to a week while cutting 
the follow up time of 4 to 6 months to 2 to 3 month’s interval as recommended by the 
National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative  (KDOQI 
guidelines. Earlier studies have suggested that an increased frequency of follow up visits 
can provide early detection and management of disease co-morbidities that accelerate the 
progression of CKD (Harley, 2013; Sarnak et al, 2003; Inker, 2014).  
As CKD progresses to ESRD, limitations on functioning in society caused by 
progressing CKD becomes evident and makes it a public health and social problem since 
patients with end stage renal disease leave the workforce and claim social security and 
disability benefits. The nephrology nurse practitioner’s contribution to the management 
of CKD which potentially helps slow down this progression will bring about a significant 
shift and social change in what is the norm of nephrology practice (Mack. et.al, 2010). 
Shifting the tasks of CKD education and co-morbidities management from the usual care 
with nephrologists to nephrology nurse practitioners do not imply delivering sub-standard 
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care; rather, it helps produce better results than specialists alone because APNs play an 
integral role in patient education and close monitoring of patient adherence through 
regular interactions to identify and  address problems early (Mack, 2010).  The World 
Health Organization (WHO) called for a departure from conventional models of 
healthcare delivery which depends on highly specialized professionals - to a public health 
approach which uses standardized, simplified and decentralized systems to maximize 
primary and specialized care (WHO, 2006).  There is an increasing need for APNs in the 
care continuum for CKD management given the 2012 recommendation by the Kidney 
Disease Improving Global Outcome (KDIGO, 2012) work group for a multidisciplinary 
approach to managing CKD. The goal is to improve the outcomes of people living with 
kideny disease.   
Problem Statement 
Without close monitoring, CKD progresses rapidly in adults with diabetes and/or 
hypertension.  What is the impact of a nephrology nurse practitioner led CKD class on 
preventing disease progression as evidenced by stable or improved serum creatinine 
(Scr), estimated glomerular filtration rate(eGFR), mean arterial pressure (MAP), 
microalbumin(Alb) and hemoglobin A1C(hgbA1c) levels?  According to the Centers for 
Disease Control and Prevention (CDC), there are greater than 20 million Americans 
living with CKD which is greater than 10% of adults (CDC, 2014). With increasing new 
CKD diagnosis and high patient-to-nephrologist ratios, delayed follow-up visits and 
disease awareness have been identified as a gap in the care for CKD patients (Harley 
(2014). According to Harley (2014), these patients need close and constant monitoring 
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for signs of progression to prevent cardiovascular events due to hypertension, 
hyperlipidemia and diabetes. Among the competencies identified in the ANNA core 
curriculum edited by Counts (2008), the nephrology APN has the ability to independently 
assess, conceptualize and diagnose complex health problems; manage acute and chronic 
renal disease in a variety of healthcare settings;  prescribe, administer, and evaluate 
pharmacologic and therapeutic treatment regimens while being able to identify, study, 
and solve complex problems in the areas of nephrology. The CKD class led by the NNP 
stresses the elements that are important for managing CKD. These include understanding 
the disease process, strict monitoring of diabetes and blood pressure trends, strict 
adherence to medication regime, dietary and lifestyle changes that stress exercise and 
weight loss, smoking cessation (if relevant) and planning for the future treatment. NNPs 
education process involves development of competencies in managing these co-morbid 
disease processes.  
According to the Institute of Medicine (IOM, 2011), the APN should be able to 
practice to the fullest extent of training and education while becoming full partners with 
physicians and other health professionals in redesigning healthcare in the United States. 
But there are cultural barriers in healthcare limiting APN scope of practice, including 
physicians’ limited knowledge about APN competencies and the potential for an 
expanded APN clinical role. Physicians’ professional organizations such as the American 
Medical Association (AMA) states that ‘APNs are not capable of providing quality, safe 
care at the same levels as physicians because physicians have longer and more rigorous 
training’ (AMA, 2010, pg1). However, the American College of Physicians (2009) 
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published a position statement that identified the important role APNs play in care 
delivery and in meeting the growing demand for primary care in chronic disease 
management. The need to support collaborative practices of nephrologists and APNs as 
health care providers in a multi-disciplinary team approach to management of CKD 
stages III and IV cannot be overemphasized (Physicians Association and American 
Association of Physician Assistants, 2014). 
Purpose 
The purpose of this project was to validate the need for  an APN role in the 
continuum care for managing CKD. The idea was to evaluate the impact of the NNP led 
CKD education class on disease progression. This was a quality improvement project 
implemented in a nephrology practice aimed at improving patient outcomes and 
preventing rapid disease progression. Data were collected from January 2014 to 
December 2016. This evaluation was completed using the case control method with 
retrospective secondary data obtained from the patients’ electronic health record. The 
desired outcome was delayed disease progression as evidenced by stable or improved 
serum creatinine (Scr), estimated glomerular filtration rate(eGFR), mean arterial pressure 
(MAP), microalbumin(Alb) and hemoglobin A1C (hgbA1c) levels.  
The framework for the CKD education class in this nephrology practice drew 
from Corbin and Strauss’s (1991) chronic illness trajectory nursing model.  The 
framework also includes aspects of Wagner’s patient self-management chronic disease 
model (Wagner, 1998) and the 2010 University of North Carolina nursing model of care 
for the patient with CKD (Neyhart et al, 2010). These models were incorporated in the 
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CKD education.  This quality improvement project addressed  the need for ongoing, 
active, patient participation in monitoring and controlling of risk factors for CKD 
progression including serum creatinine, glomerular filtration rate, hemoglobin A1C, 
mean arterial blood pressures, diet and exercise, hyperlipidemia with lifestyle changes – 
an identified gap in practice for managing CKD. 
The guiding question (practice-focused) for this scholarly project was as follows:  
            In adults with advanced chronic kidney disease, diabetes and/or hypertension, 
what is the impact of a NNP- led CKD class on preventing disease progression as 
evidenced by stable or improved serum creatinine (Scr), estimated glomerular 
filtration rate(eGFR), mean arterial pressure (MAP), microalbumin(Alb) and 
hemoglobin A1C(hgbA1c) levels?    
CKD patients in this practice are seen in follow up every 4 - 6 months, which is 
inadequate for effective monitoring of this disease process (National kidney Foundation, 
2012). APNs working in nephrology practices are used for dialysis rounds for the three 
out of four visits per month required by Medicare and other payers and as scribes in the 
hospital settings. The education and wealth of knowledge APNs acquired in training as 
managers of chronic and acute illness are not put to good use when working in a 
nephrology service. By presenting research evidence of APNs management of chronic 
illness, this doctoral project could close this gap in practice about the need for APNs as 
team members in managing CKD.  
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Nature of Doctoral Project 
This program evaluation of a quality improvement project used the case control 
method with retrospective secondary data collected from health records to evaluate the 
impact and effectiveness of NNP-led CKD classes on CKD disease progression. Quality 
indicators related to measured disease progression includes serum creatinine (Scr), 
estimated glomerular filtration rate(eGFR), mean arterial pressure (MAP), 
microalbumin(Alb) and hemoglobin A1C(hgbA1c) levels. Inference was drawn from the 
result to justify the need for including the APN in the continuum of care for the CKD 
patient.  Secondary data were collected from a nephrology group practice’s routine 
laboratory results in Dayton, Ohio. This practice employs 11 nephrologists, one 
physician’s assistant, and three nurse practitioners. It has four satellite offices with 
admitting privileges to the four major hospitals in the Dayton metropolis area. 
Retrospective secondary data was collected from adult CKD Stages III and IV patients 
with diabetes and/or hypertension over a period of one year.  Data were analyzed and 
subjected to comparisons between patients who received usual care and those who in 
addition, attended the NNP-led CKD class. Although attendance was not mandated but 
strongly suggested for new patient, some patients choose not to attend. Reasons for not 
attending these free classes have ranged from transportation issues to timing of the 
classes that are usually held in the evening and patients’ unawareness of the role of the 




 The major stakeholders for this project are the people diagnosed with CKD who 
benefitted from attending the CKD class as evidenced by delayed disease progression.  
Other stakeholders who benefitted included referring primary care physicians, insurance 
payer’s (Medicare / Medicaid and private insurers); nephrology practices – which will 
have access to new revenue source even though it is paid at only 80% of  the current 
specialist  pay rate per visit in addition to improved follow up; nurses and nursing in 
particular, ANNA advocates  and policy makers. With the APN role at the apex of 
clinical nursing practice, there has been a renewed interest in, and debate about, 
expanding the APN roles worldwide in assessing and managing of chronic illness using 
nursing knowledge and skills in an autonomous or collaborative setting (Spiteri, 2008). 
The dissemination of findings are expected to support the innovative management of 
chronic diseases in the primary care setting and thus enable the emergence of other 
practice patterns. 
The results of this project could have national implications for CKD patients: A 
decrease in the rate of new ESRD cases and better inclusive management of CKD have 
far reaching clinical, social and public health implications. With the extensive burden of 
CKD disease in the United States and an economic impact of an estimated nearly $1 
trillion, CKD has potentially devastating effects on the socio-economic welfare of the 
population and, as such, any effort made to limit the impact of this disease would be 




CKD is a devastating and expensive chronic disease that currently is 
undermanaged. The Patient Protection  and Affordable Care Act of 2010 provided 
insurance coverage for many uninsured, but it had an unexpected consequence in the 
Dayton Ohio area: an influx of new CKD diagnosis that overwhelmed the few area 
nephrology practices. These nephrology practices employ APNs, but use them as scribes. 
However, it is counterproductive to alienate nurse practitioners who have been validated 
as exceptional providers of care for the chronically ill CKD patients. Stakeholders in the 
CKD management will each benefit from the addition of the APN to the care continuum.  
Section 2, the literature review, covers the following topics: background, and 
concepts, models and theories supporting the identified gap in practice and the role of the 
DNP in the project. 
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Section 2: Background and Context 
Introduction 
Chronic Kidney Disease (CKD) is a condition characterized by the gradual loss of 
kidney function. It is described as a progressive decrease in GFR or a progressive 
increase in albuminuria that raises a patient’s risk of developing several life threatening 
conditions including end stage renal disease (ESRD) and cardiovascular disease (CVD) 
(UMHS, 2014). Patients who are in the progressive Stages III and IV CKD which is 
estimated glomerular filtration rate between 15 to 60 ml/min/1.73m2 are known to 
experience a higher rate of cardiovascular events that lead to death than those in the 
earlier stages of CKD (Allen et al, 2011). In managing the CKD patient, including an 
APN in the continuum is an identified gap in practice that could help delay the 
progression of this deadly condition (Easom & Allbritton, 2000). Current practices in the 
target nephrology group practice call for the management of CKD by the nephrologist 
alone. However, given the number of CKD patients, there are not enough nephrologists 
available in the Dayton Ohio area population of 801,259 (USA, 2016).  The aavailable 
nephrology groups schedule follow up visits with CKD patients every 4-6 months, which 
is grossly insufficient to purposefully manage and prevent the progression of CKD to 
ESRD.  The purpose of this doctoral project was to evaluate the impact of a NNP-led 
CKD education class on preventing disease progression. Evidence of impact will be 
stable or improved serum creatinine (Scr), estimated glomerular filtration rate(eGFR), 
mean arterial pressure (MAP), microalbumin(Alb) and hemoglobin A1C(hgbA1c) levels 
in adults CKD Stages III and IV patients with hypertension and /or diabetes.  In section 2, 
12 
 
I will name, describe and provide rationale for the use of all concepts, models and / or 
theories that inform the project. I will be highlighting the role of the DNP and its 
relevance to nursing, the local background and context.  
Concepts, Models, and Theories 
The conceptual framework for this scholarly project was based on the chronic 
illness trajectory nursing model of Corbin and Strauss (1991). Here, the model guides the 
CKD education goals: it identifies the phases of chronic illness, identifying the problems 
associated with it; it establishes goals for management and implementing interventions.  
Not only does this helps the APN become familiar with the patients’ point of view of his 
or her illness, but it can become a management instrument for chronic illness. This was 
echoed by Orem’s self-care deficits theory (Orem, 1995), whose key concepts are self-
care, self-management and self-maintenance. These three concepts were addressed by 
Riegel, Jaarsma and Stromberg (2012) who posited that the important intended outcomes 
of self-care in chronic illness are illness stability, health and wellbeing, decreased anxiety 
and good quality of life with perceived control over illness.  
CKD education in its current state draws from the chronic illness trajectory 
nursing model of Corbin and Strauss (1991). CKD education was developed to promote 
holistic nursing process in chronic illness stressing supportive assistance in the absence of 
cure that would allow the individual to participate in shaping the course of the illness 
while maintaining independence and some form of normalcy.  It focuses on the ever-
changing role of patients in managing symptoms, disability and outcomes that will 
impact disease management (Corbin & Strauss, 1991). The linking factors that influence 
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self-care include support from others and access to care, motivation, experience, skill, 
cultures, confidence and cognition.  In the initial definition of nursing concerns, Orem 
(1995) stated that in order to sustain life and health recover from injury or disease and 
cope with their effects, individuals need the provision and management of self-care 
action on a continuous basis. Orem identified self-care as a human regulatory function 
that individuals must with deliberation perform themselves or have performed for them to 
maintain life, health, development and wellbeing.  
Self-care management taught in the CKD classes encompasses human needs and 
interventions meant to assist in recovering or maintaining health (Taylor, Lillis, LeMone, 
and Lynn (2011). Riegel, et al. (2012) posited that self-care maintenance, self-care 
monitoring and self-care management are core elements of the self-care of chronic illness 
of which self-care monitoring is a distinct concept and remains a bridge between self-care 
maintenance and self-care management. The above-mentioned concept and theoretical 
framework support the premise of establishing the CKD class - the chosen model for 
evaluating the impact of the NNP in managing CKD. Another framework that the CKD 
class draws from is the chronic care model (CCM).  Fiandt (2006) argued that the 
Chronic Care Model (CCM) arose from the need for an organizing framework that seeks 
to improve chronic illness care at both the individual and population level. It is based on 
the assumption that improvement in care requires an approach that incorporates the 
patient, the provider and system level interactions. The NNP is ideally suited for 
intervention through the CCM based CKD class. Although the CCM was developed two 
decades ago, this approach has been widely adopted to improve care in the ambulatory 
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setting and to guide quality clinical initiatives. Evidence supports the use of CCM in 
guiding the designation of care to improve health outcomes (Mattke, Seid, & Ma, 2007).  
Evidence suggests reduced cost of total healthcare resulting from improved disease 
control interventions although early practices that redesigned along the lines of CCM lost 
money in the short term, the reduction of the risks of ESRD, Coronary artery disease, 
blindness, loss of body parts and increase in quality adjusted life years (QALYS) is 
considered cost effective for society (Mattke, et al, 2007).  Evidence from studies have 
suggested that implementation of any or all the CCM based guideline and principles in 
practices results in improved quality outcomes in people with chronic conditions 
(Wagner, Davis, Schaefer, Von Korff, & Austin, 2002; Bonomi, Wagner, Glasgow, & 
Von Korff, 2002; Coleman, Austin, Brach, & Wagner, (2009).  For a practice redesign 
like CKD education class to be defined as CCM based, it has to embrace the six areas 
stipulated by the model – self-management support,  a delivery system design, decision 
support , use of community resources, healthcare organizations and clinical information 
systems(Coleman, Austin, Brach, & Wagner, 2009). The ability to address the 
multifactorial nature of chronic problems in chronic disease management places the nurse 
practitioner in a position to address the complex sets of actions that address psychosocial, 
physical and lifestyle issues affecting patients.  In a study by Asch et al. (2005), 
congestive heart failure patients who participated in a chronic disease care based 
management class visited the emergency room less and experienced fewer 
hospitalizations.   
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The CCM based CKD class defines self-management as the decisions and 
behaviors that patients with chronic illness engage in that affect their health (Fiandt, 
2006). The goal of self-management support is to empower and prepare patients to 
manage their health and healthcare (Bodenheimer, Lorig, Holman, & Grumbach, 2002; 
Norris, Lau, Smith, Schmid, & Engelgau, 2002).  Research suggests that developing self-
management skills can have a significant positive effect on health outcomes of people 
with chronic illnesses.  It is the role of the APN using the self-management support tool 
to help patients understand their central role in managing their illness, making informed 
decisions about care, and engaging in healthy behaviors.  
In a study that examined the impact of the role of the APN in chronic disease 
management, the Canadian Prevention of Renal and Cardiovascular Endpoints Trial 
(canPREVENT) studied a nurse coordinated model of care versus usual care in stages III 
and IV CKD patients. The study conducted by Barretts et, al. (2011) posited that chronic 
disease care by a nurse practitioner can substitute for specialist care as evidenced in the 
use of cost effective strict evidence based guidelines for disease management with or 
without supervision. The impact of the cost effective quality care provided by the APN in 
chronic disease management has been echoed in several studies (Coresh et al, 2007; 
Parker, Ibrahim, Shaffer, Rosner, & Molitoris, 2011). In the above mentioned studies, the 
common set of challenges presented to chronic illness sufferers that include death and 
disability, emotional and financial devastation, complex medication regime, and difficult 
lifestyles adjustments were successfully addressed by the APN. These common set of 
challenges are addressed by APN supervised and managed CKD education since a 
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majority of new CKD patients are unprepared to self-manage their illness. For a 
successful management of a chronic illness, the patient needs to be equipped to be in 
control with carefully followed plan in conjunction with their treatment team.  A recent 
Cochrane collaboration review suggested that busy practices can redesign their care 
system to incorporate the CCM values for quality healthcare delivery stating that the 
greater and more complex an intervention for chronic illness, the greater chance of 
success (Renders et al., 2001). The NNP-led CKD class is a good example of this quality 
improvement effort. 
Project Relevance to Nursing Practice 
APNs plays a vital role in CKD management by educating patients on the 
importance of maintaining good glycemic control, blood pressure control and lifestyle 
modifications – three key factors in preventing progression of kidney disease. In the past, 
prior to the introduction of the APN role, nursing management of CKD using the nursing 
process has been limited to assessment phase and documentation of cardiovascular, 
respiratory, gastrointestinal, neurological, integumentary, musculoskeletal, 
immunological, hematological symptoms of CKD. This leaves out the diagnosing, 
planning, implementing and evaluation phases of the nursing process to complete the 
scientific method that ensures quality patient care. Virginia Henderson while questioning 
the nursing process title  as to whether problem solving is all there is to nursing noted that 
the nursing role  should include collaboration with healthcare professionals and the 
development of the clients self-reliance rather than  just learning what a patient‘s 
immediate needs are and how to meet them (Henderson, 1982). Evidence has suggested 
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that APNs can improve chronic illness care by communicating effectively with patients in 
understanding their illness and treatments (Bodenheimer, MacGregor, & Stothart, 2005). 
Management of CKD requires a multidisciplinary approach comprising of nephrologists, 
primary care providers, advance practice nurses, pharmacists, nurses, dietitians, and 
social workers but current practice barriers to optimal management of CKD abound. The 
NKF – Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) guidelines that have 
become the basis for the management of CKD were based on a systematic review of 
literature recommendations, however , there was emphasis directed towards drug 
therapies to be managed by internists and nephrologists. The KDOQI guidelines failed to 
integrate nursing care in the care continuum for CKD. The guidelines for evaluation, 
classification and stratification of CKD defined CKD as an abnormality of kidney 
structure or function present for greater than three months, with implications to health 
irrespective of cause or specific clinical presentation (Inker, Isakova, & Peralta, 2014). 
The above mentioned guideline proposed a staging system based on the glomerular 
filtration rate (GFR) progressing naturally from stage I to stage V. The GFR is the best 
measure of overall kidney function as a normal GFR in young adults is approximately 
120 -130 mL/min per 1.73 m2 and declines with age (Inker et al., 2014).  
The current state of nursing practice in the management of CKD which is almost 
non-existent in the Dayton, Ohio area as APNs working in nephrology practices been 
relegated to assessment of hospitalized patients and making dialysis rounds which 
negates the quality management skills APNs have acquired in the continuum of chronic 
disease management. Although the role and scope of practice for the dialysis APN has 
18 
 
been defined in North America, unfortunately the focus should be in the pre-dialysis 
CKD care as the disease progresses through the stages where individuals are at risk of 
cardiovascular disease and death.  With an increasing risk of disease progression to end 
stage renal disease (ESRD), patients with CKD are faced with considerable morbidity, 
mortality, diminished quality of life, and high health care costs (Ruggenenti, Schieppati 
& Remuzzi, 2001).  Fortunately, there is growing evidence in literature that supports the 
idea that early recognition, intervention and treatment of CKD can help to slow down or 
prevent the devastating progression of this disease. Studies have suggested that 
development of ESRD from CKD can be stemmed by patient awareness by CKD 
education and a multifactorial treatment approach following earlier detection through 
weight reduction, blood pressure control, improved glycemic control, reduction of 
proteinuria, smoking cessation, lipid lowering therapy and intensified follow up 
interventions (Hsu, McCulloch, Iribarren, Darbinian & Go, 2006). The roles of 
hypertension and diabetes in progressive decline of renal function have been established 
by previous research and nurse practitioners are well trained to manage these risk factors. 
In a quality improvement report, Spiteri (2008) stated that strategies have been 
put in place in Victoria, Australia to stem the gap in practice caused by inadequate 
practicing nephrologists by creating the renal nurse practitioner position. This strategy 
calls for a hospitalist based APN who conducts office follow up visits, for acute/chronic 
care and post-transplant CKD stages III and IV management. There is a community based 
renal nurse practitioner for CKD V and ESRD patients working in home and satellite 
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dialysis centers. This process ensures continuity of care, education and sustainable 
nursing role. 
Delaying the progression of CKD and preventing  new cases with its attendant 
complications, disabilities, associated morbidity (death) and economic costs are the key 
goals of the Healthy People (HP) 2020 CKD objectives (HP 2020, 2015). A revised 
Healthy People 2020 CKD -8 objective called for reducing the number of new cases of 
ESRD, reducing the kidney disease burden, removing the disparities among kidney 
disease patients and improving the quality of life while promoting longer lives  in order 
to meet the objectives for CKD Healthy People 2020 initiative. This will involve a 
modest reduction in new cases of ESRD in the region from a baseline of 382.6 new cases 
per a million, which was reported in 2007 and adjusted to race, age and sex to about 
344.3 new cases per million populations – a 10 percent improvement (HP, 2015). 
Currently, 14 of the 24 HP2020 CKD targets and objectives have been met or moved 
towards the 2020 target. Using about 25% of Medicare budget, CKD and ESRD are cost 
intensive (Friedman & Friedman. 2006). The financial burden of CKD and ESRD on 
Medicare CKD/ESRD expenditures for 2014 totaled $49.3 billion (CDC, 2014). 
This project evaluated the role of the NNP as an educator in the management of 
CKD.  Inference was drawn from the success of the CKD education class to address the 
need to include APNs in the care of the CKD patient to advance nursing practice.  
Local Background and Context  
Although the number of individuals with GFR <15 ml/min/1.73m2 who do not 
receive hemodialysis or peritoneal dialysis treatments  has not been estimated reliably, 
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the ratio of CKD patients to ESRD patients  has been noted to be about 9:1 (Levey, 
2012).  To gain insight about the extent of kidney disease pandemic in the greater 
Dayton, Ohio area, an overview of the increasing number of new hemodialysis and 
peritoneal centers is important.  These centers are offering hemodialysis and peritoneal 
dialysis services to ESRD patients and follow up with kidney transplant recipients. 
Majority of these centers offer three to four shifts a day for patients and seats about 25 to 
35 patients per shift. The population of the greater Dayton area in 2011 was placed at 
801,259 (USA, 2016) with 51.1 % females and 48.9% male. The average estimated 
median household income in 2013 was $47,162.  The metropolitan area boasts of two 
major groups of nephrologists and fifteen hemodialysis centers. Following the closing of 
General Motors plants in Dayton, the local economy suffered a setback with majority 
loosing health insurance. 41.2 % of the Greater Dayton population is of African 
American descent (USA, 2016) that has a greater tendency to have diabetes and 
hypertension diagnosis. They are responsible for the rapid increase in patients with newly 
diagnosed CKD. Delaying the progression of CKD in this group is of paramount 
importance.  The passing of the Affordable Care Act (ACA) healthcare law of 2011 
provided previously uninsured persons with health insurance and a fall out was an 
increased number of new diagnoses of CKD in patients who previously did not seek 
primary care. With a handful of nephrologists in practice and the influx of new referrals, 
the average wait time for a nephrology consult and follow up has doubled (Osinski, 
2012). The majority of referrals come from post-hospital admissions follow ups and 
physician office referrals. The Ohio Valley and the Greater Dayton area do not have 
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enough nephrologists to adequately care for the rising number of CKD patients.  In the 
global burden of death study (2013), CKD related death increased from 409.000 in 1990 
to 956, 000 in 2013. For patients who are living with CKD, the daily chore and burden of 
managing other chronic conditions such as diabetes or hypertension usually requires 
substantive changes in way of life. The socio-economic, emotional and medical aspects 
of the disease process leads to challenges for the community. These are currently being 
addressed by the many awareness rallies and social group’s intervention for early 
diagnosis and prevention of diseases like diabetes and hypertension. Partnerships with the 
healthcare providers have been forged with organizations like the American Diabetes 
Association (ADA) and the National Kidney Foundations who have programs geared 
towards enlightenment of the public to symptoms.   
NNPs are trained to help patients navigate the tortuous terrain of chronic kidney 
disease that is frightening with strategies that are tailored to the stages of the disease 
(Thomas-Hawkins & Zazworsky, 2005).  In a research conducted on the impact of socio 
economic factors on quality of life of patients with CKD, Ikonomou, et al (2015) posited 
that people with CKD present with a poor quality of life and added to their burden of the 
renal disease are social and economic factors (divorce, financial difficulties) which seem 
to worsen their financial status since health care costs at baseline and follow-up are 
higher for patients with CKD.  CKD is a public health problem in the Dayton, Ohio area. 
According to the United Network for Organ Sharing (UNOS), there have been 2,495 new 
patients placed on the Kidney transplant waiting list in Ohio since January 2016 (UNOS, 
2016). With six outpatient clinics for the uninsured and underserved inner city dwellers in 
22 
 
the Dayton area, the rate of referrals for management of CKD and application rates for 
Medicaid coverage of ESRD has doubled in this area as well as waited patients on the 
kidney transplant list for the two major transplant centers in the region (UNOS , 2016).  
Added to this list are the high intake numbers from the 15 hemodialysis centers in the 
Dayton metropolis that run 3-4 treatment shifts of approximately 32 patients per center 
per shift. 
While the International Society of Nephrology (2006) has opined that the 
preservation of renal function and prevention of progression to end stage renal disease is 
the most essential goal of nephrology care, the NKF (2002) stressed the importance of 
early identification and treatment of people with chronic kidney disease.  Inker, et al 
(2014) argued that the evaluation and treatment of CKD patients requires an intricate 
understanding of the separate but related concepts of the diagnosis, comorbid conditions, 
severity of disease, complications of disease, and risks for loss of kidney function and 
CVD.  While advocating for a coordinated multifactorial and multidisciplinary approach 
to improve the management of CKD, Valderrabano et al., (2001) observed that with a 
higher than normal morbidity and mortality rates associated with CKD and subsequent 
ESRD, several factors continue to mitigate optimal and coordinated management of CKD 
that includes uncoordinated care plans, attitudes of available nephrologists, late 
identification and referral of CKD patients, poor follow-up visits arrangement.  
While justifying the need for the NNP role in management of CKD, the American 
Society of Nephrology (ASN) in a recent report noted a decline in the number of medical 
residents filling nephrology fellowships from 91% in 2012 to 69 % in 2015 which 
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translates to a dire shortage of nephrologists in the next decade (Charnow, 2016). Data 
from the Renal Physician Association 2003 benchmark survey shows a patient – 
nephrologist ratio of 68:1. This number has doubled in the past year with the Health 
Insurance Portability and Accountability Act (affordable health care insurance) 
accounting for new diagnosis of CKD / ESRD estimated at over seven million (Osinski, 
2012). The growing incidence and prevalence of kidney disease have raised concerns 
about the sufficiency of available nephrologists and other kidney care specialists. 
Role of the DNP Student 
The role of the DNP student in this project included identifying the project, 
engaging and recruiting the client, setting measurable objectives for the project, defining 
the problem, participating in the CKD class instructions, collecting data needed for 
evaluating the project performance and producing a written report on the findings. As a 
DNP student undergoing the practicum project in a nephrology group setting, the author 
had opportunities to participate CKD education to patients with stage III and IV who 
have both diabetes and hypertension and as such it is a great setting to evaluate the 
impact of the CKD class on disease progression. Quality skills acquired in the DNP 
program imbue the student with the managerial and leadership skills as change agents in 
the ever changing landscape of healthcare (Gillam & Siriwardena, 2013).  Change agents 
assess the suitability of the environment in handling the implementation of change. In this 
project, the DNP student role was to measure the impact of the CKD education on disease 
progression by reviewing patients serum creatinine levels, estimated glomerular filtration 
rates, mean arterial pressures, hemoglobinA1C and urine protein. 
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Quality healthcare has been described by the IOM (2013) as the degree to which 
healthcare services for individuals increase the likelihood of desired health outcome 
consistent with current professional knowledge.  This opinion was echoed by Stevens 
(2013) who sees a solution to the ‘Crossing of the Chasm’ issue in evidence-based 
practice (EBP) - an integration of the best research evidence with clinical expertise and 
patient values to provide the ultimate care for the patient. Doctor of Nursing Practice 
(DNP) and Advance Practice Nurses (APNs) training is geared towards providing 
evidence based care. In this era of reformation in healthcare delivery, the focus has been 
on the concept of Triple Aim – reducing costs, better population health, and an improved 
patient experience. The context of this project and the DNP role involved using evidence 
based CKD education in CKD patients in a nephrology practice clinic to deliver quality 
care that is measurable as part of a high-functioning health care team (IHI, 2016). As part 
of the requirement of a DNP graduate, translating research into practice by evaluating, 
analyzing and extrapolating practice data to improve the reliability of the healthcare 
practice and outcome, My plan was to integrate applied scholarship through evidence 
based generated guidelines and to evaluate clinical outcomes with the chronic care model 
approach to CKD management based on an interprofessional collaboration that will 
ensure nursing has equal representation in the care team.    
Standardized guidelines generated from the synthesis of major studies like the 
Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid 
of Nurse Practitioner (MASTERRPLAN) (Peeters et al., 2012) and the canPREVENT 
trials (Coresh et al., 2007) are being used by nurse practitioners in managing CKD risk 
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factors in nephrology practice setting or stand-alone clinics in Australia and New Zealand 
(Spiteri, 2008). With the goals of defining CKD and its stages, stratifying risk for kidney 
loss, evaluating laboratory measurements and cardiovascular disease prevention, the 
KDOQI report recommended an evidence based action plan for CKD patients. - A Level 
B recommendation of the KDOQI guidelines states that patients with CKD should be 
referred to a specialist for consultation and co-management if the person’s personal 
physician cannot adequately evaluate and treat the patient. It went on to call for a 
nephrologist to participate in the care of the patient with a GFR less than 30 ml/min per 
1.73 m2 (Inker, et al., 2014). This has been the biggest criticism of the report so far - the 
failure to involve the patient and allied health professionals in the management of this 
chronic illness whose effects are far reaching and transcends healthcare. The use of 
evidence based guidelines is the standard of practice for an APN and as a DNP student, 
my role is to implement and translate research generated evidence to improve quality of 
healthcare services to the patient.  
The Updated Guidelines (KDOQI, 2012) endorsed a model of shared 
responsibility between primary care physician’s pharmacists, social workers, dieticians, 
physician assistants and nurse practitioners and specialists (nephrologist) of patients 
diagnosed with CKD in a multidisciplinary model. Peeters et al (2014) surmised in the 
renal endpoints of the Multifactorial Approach and Superior Treatment Efficacy in Renal 
patients with the aid of Nurse Practitioners (MASTERPLAN) study that additional 
support by nurse practitioners attenuated the decline of kidney function and improved 
renal outcome in patients with CKD. In that study which randomized 788 patients with 
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severe CKD to receive nurse practitioner support added to physician care (intervention 
group) or physician care alone (control group), significant differences were observed with 
improvement in the intervention groups blood pressure, serum creatinine, proteinuria, and 
use of antihypertensive thereby reducing the composite renal endpoint incidence by 20% 
(Peeters et al., 2014 (Pg. 391) 
Motivations for this doctoral project came from witnessing delayed care given to 
CKD patients whose current care is aligned to preparing them for dialysis in a disease 
process that can be delayed. The co-morbidities that hasten the rapid transition from CKD 
to ESRD are disease processes that the APN is trained to manage with proven success. 
Another motivation for this doctoral project is to justify the need for the inclusion of 
NNP in direct management of both CKD and ESRD patients rather than using their 
services only for dialysis rounds and hospital scribe duties when they are employed by 
nephrology groups. This goes against the IOM recommendation # 1 that APNs should be 
able to practice to the full extent of their education and training by urging the removal of 
scope – of – practice barriers. This APN was motivated by the successes of APNs in 
clinical and randomized trials that evaluated a nurse led disease management program for 
CKD.  Wong, Chan and Chow (2009) posited that the study which employed an 
innovative model of skills mix by using specialists with general nurses demonstrated 
patient improvement in diet non adherence, aspects of quality of life and satisfaction with 
care. Peeters et al (2014) further clarified that nurse practitioners on the average spent 26 
minutes per visit on patient care while physicians spent the usual 10-15 minutes.  
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Studies have suggested that patients’ outcome in the primary and ambulatory care 
setting where they were treated by a nurse practitioner and physician were comparable. In 
a randomized trial Mundinger et al. (2000) posited that there were no significant 
differences found in self-reported patients’ health status with regards to physiologic test 
results for patients with diabetes and hypertension following treatments over 6 months by 
nurse practitioners versus physicians, for patients with hypertension, the diastolic value 
was statistically significantly lower for nurse practitioner patients (82 vs 85 mm Hg; P = 
.04). It can thus be argued that in the traditional medical model of primary care, patient 
outcomes for nurse practitioner and physician delivery of primary care do not differ 
(Mundinger et al., 2000).  Similarly, in a systematic review by Anderson, Salisbury and 
Horrocks (2002) of whether nurse practitioners working in primary care can provide first 
point of contact care equivalent to doctors, it was concluded that nurse practitioners 
provide longer consultations and carry out more investigations than doctors leading to 
higher levels of patient satisfaction and high quality care. 
Potentials for bias exist in every project or research study especially when the 
researcher has vested interest. In this case I am a certified Advance Practice Nurse 
investigating the effects of adding the APN role to the CKD care continuum. In order to 
mediate tendencies for bias in this project, I have chosen to use the case controlled 
research method by creating a project design that uses set criteria for recruiting the 
population, randomizing participants to groups, employing the services of medical 
assistants who are blinded to the different groups for data collection, avoiding surveys, 
using new CKD patient referrals to the clinic. In my role as an advocate for the IOM 
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recommendation for the removal of scope of practice barriers, the above mentioned 
biases are expected, but steps are being taken to mitigate them by adhering strictly to 
available data within the time frame of study.  
Summary 
CKD is a progressive disease in patients with hypertension and diabetes. The 
nurse practitioner led CKD classes is based on  Corbin and Strauss’s (1991) chronic 
illness trajectory nursing model. The concept of self-management was explored based on 
the self-care theories of Orem as a working framework that involves applying the chronic 
illness trajectory model for disease management to CKD management by the nurse 
practitioner in collaboration with a nephrologist. This line of thought is supported by 
evidence of APN measurable success in management of CKD co-morbidities. This 
evidence can be translated into practice by using evidence generated guidelines in the 
management of the CKD patient. The results of success or not can be surmised from 
evidence gathered from patients through laboratory reports on serum creatinine, 
estimated glomerular filtration rate (GFR) interval change, microalbumin levels, mean 
arterial pressures and hemoglobin A1C collated with permission by Medical assistants in 
a nephrology office on new CKD patients at onset and 3, 6 and 9 months. During this 
interval, project participants would have undergone the CKD class or did not participate. 
The DNP student’s role in the project involved identifying the project and client, 




Section 3 will address the methods of collection, sources of evidence, data 























Section 3: Collection and Analysis of Evidence 
Introduction 
The purpose of this project was to evaluate the impact of the nephrology nurse 
practitioner led chronic kidney disease class on patient outcomes. This evaluation 
followed a quality improvement project implemented in a nephrology practice aimed at 
preventing rapid disease progression for the period extending from January 2014 to 
December 2016.  The key elements of the CKD education class (see Appendix C) 
included understanding disease process, strict diabetes and blood pressure monitoring and 
management (BP and RAAS interruption) (Glycemic Control), salt restriction, 
medication adherence, dietary and lifestyle changes - exercise and weight loss, smoking 
cessation and planning for the future – treatment options for dialysis/transplantation. This 
evaluation was completed using the case control method with retrospective secondary 
data collection from the electronic health record. 
Practice-focused Question(s) 
In the Dayton Ohio area, there has been a disproportionate increase in end stage 
renal disease patients and a new wave of recently diagnosed CKD patients. A question 
has arisen as to what needs to be done to stem this rapid progression from CKD to ESRD. 
Current practice amongst the nephrology groups who get referrals for these CKD patients 
is to have APNs in their practice cover dialysis rounds or assist as scribes in hospital 
rounds. It has been argued that APNs who have received extensive training in managing 
CKD co-morbid conditions should be involved in the management of CKD. The delay in 
care of the CKD patient determined mostly by the long-time interval from referral to 
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initial consults and extended follow ups is an identified gap in practice for the care of the 
CKD patient. A guiding practice focused question for this scholarly project was “In 
adults with advanced chronic kidney disease, diabetes and/or hypertension, what is the 
impact of a nephrology nurse practitioner led CKD class on preventing disease 
progression as evidenced by stable or improved serum creatinine (Scr), estimated 
glomerular filtration rate (eGFR), mean arterial pressure (MAP), microalbumin (Alb) and 
hemoglobin A1C (hgbA1c) levels. 
Sources of Evidence 
          To evaluate this quality improvement project implemented in a nephrology 
practice from January 2014 to December 2016, a case-control method with retrospective 
secondary data collected from the electronic health record was used.  The patient 
population was made up of adult CKD stages III and IV patients with hypertension and 
Diabetes in a nephrology practice in Dayton, Ohio.  The evidence for this project was 
based on secondary data made up of baseline measurements of mean arterial blood 
pressure(MAP) obtained at scheduled office visits and documented in the electronic 
medical record (EMR). Data was collected and documented on each office visit by 
medical assistants. Laboratory data pertaining to hemoglobin A1C, eGFR, microalbumin, 
serum creatinine was extracted from electronic health record. Each patient in the 
nephrology practice has scheduled labs prior to visit. According to Friss and Sellers 
(2014), a case control study is designed to help determine if an exposure is associated 
with an outcome. Case control studies compare two groups – the case and the control. 
These are CKD patients who were randomized into two groups. One group - the case – 
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was made up of advanced CKD patients with hypertension and/or diabetes who received 
routine office visit instructions and participated in the nephrology nurse practitioner led 
CKD education class, while the control group were CKD patients who received usual 
care instructions within the nephrology office visit. Patients who fitted the inclusive 
criteria are advanced CKD stage III and IV patients with hypertension  and/or  diabetes 
who have received the CKD education class that addressed  understanding disease 
process, strict diabetes and blood pressure monitoring and management (BP and RAAS 
interruption) (Glycemic Control), salt restriction, medication adherence, dietary and  
lifestyle changes - exercise and weight loss, smoking cessation and planning for the 
future – treatment options for dialysis/transplantation (see appendix C). Excluded from 
the project were patients diagnosed with acute renal failure (ARF), renal transplant 
recipients, patients with progressive glomerular-nephritis (GN), and patients with HIV or 
any oncological diagnosis. Informed consent from the participants was not needed as this 
was an evaluation of a quality improvement program using retrospective secondary data; 
the IRB (Ethics) committee approval was obtained prior to data collection.  
Analysis and Synthesis 
          To obtain a robust quality data, a patient chart review to determine 
eligibility for inclusion or exclusion was conducted. Supportive secondary data from 
electronic health record of routine laboratory results was collected about estimated 
glomerular filtration rate (eGFR), serum creatinine, micro albumin and protein-creatinine 
ratio and blood pressures by medical assistants (MA) employed at the nephrology 
practice office. Retrieving baseline clinical data from the electrical medical records and 
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paper charts will be done by medical assistants in the practice under close supervision 
and blinded to group allocation. Data extracted by the medical assistants was cross-
checked prior to finalizing documentation and analysis.  Data as collected from first visit 
or consult served as baseline, at the six months visit after attending the class or not and 
one year after visit. Desired outcomes measured was improved or stable renal function in 
the case group as exemplified by stable or decreased serum creatinine, improved eGFR, 
improved blood pressure readings and MAP, decreased proteinuria and hemoglobin A1c 
especially in the case group.  The KDIGO guideline did not address screening for CKD 
among specific populations, but recommended assessment of the risk for developing 
CKD for all individuals, with measurement of blood pressure, albuminuria, and serum 
creatinine to estimate the GFR among those at higher risk (Inker et al., 2014). Data was 
analyzed using the mean  and standard deviation for the measured variables in the groups. 
In comparing the mean scores of each outcome measure amongst the two groups at each 
period, the independent t-test was used. The researcher used the SPSS(S) statistical 
program 21.1 for windows in the calculation of mean creatinine, hga1c, map, eGFR and 
microalbumin for patients who participated in the CKD education class and those that did 
not participate. Patients with incomplete data – laboratory results at the starting point, 
midway or at the end were excluded from the report.  
Summary 
This doctoral project addressed the need to include the nurse practitioner in the 
continuum of care for the CKD patient. It addressed the question – In adults with 
advanced chronic kidney disease, diabetes and/or  hypertension, what is the impact of a 
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nephrology nurse practitioner led CKD class on preventing disease progression as 
evidenced by stable or improved serum creatinine (Scr), estimated glomerular filtration 
rate(eGFR), mean arterial pressure (MAP), microalbumin(Alb) and hemoglobin 
A1C(hgbA1c) levels?  Will the addition of the APN in the continuum of care stem the 
progression of CKD to ESRD. Evidence from retrospective secondary data from the EHR 
at the nephrology practice were collected and analyzed. Collated data was analyzed using 
the descriptive statistics data with means, standard deviation, Independent t-test for 
comparison of outcomes. 
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Section 4: Findings and Recommendations 
Introduction 
          With increasing new CKD diagnosis and high patient to nephrologist ratios, 
Harley (2014) stated that delayed follow-up visits and disease awareness are an identified 
gap in care for the CKD patient. The problem statement guiding the project is the impact 
of a NNP led CKD class on preventing disease progression in adults advanced CKD 
patients with diabetes and/or hypertension.  
The purpose of this project was to evaluate a quality improvement program – an 
NNP led CKD education class, from 2014 to 2016, in a nephrology practice in Dayton, 
Ohio. The CKD education program was initiated for newly diagnosed CKD patients in 
the practice to teach them about the disease process along with the nephrologist’s routine 
instructions during routine visits. The objective was to delay disease progression. The 
results justified the need for including the APN in the continuum of care for CKD 
patients. 
 This evaluation was completed using the case control research method with 
retrospective secondary data collected from the patient’s  electronic health record. The 
desired outcome was delayed disease progression measured by decreased serum 
creatinine levels, decreased estimated glomerular filtration rate (using the chronic kidney 
disease epidemiology collaboration equation); decreased mean arterial pressures, 
hemoglobin A1C, and microalbumin. Data collected was from documented laboratory 
records obtained at each patient’s office visit by medical assistants during the initial visit, 
six months later and at 1-year mark. Inclusion criteria was CKD stage III and IV patients 
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with hypertension and/or diabetes and eGFR of 59 to 15 ml;/min per 1.73 m2. Excluded 
from the project were patients with acute renal failure, renal transplant recipients, patients 
with progressive glomerular-nephritis, and patients with any hematological /oncological 
diagnosis. Data from patients who fit the inclusion criteria were assigned to two groups – 
the case and control groups.  The case group was made up of CKD stage III and IV 
patients with hypertension and/or diabetes who received routine office visit instructions 
and participated in the NNP- led CKD education class, while the control group was made 
up of CKD patients who received usual care within the nephrology office visit. 
Findings and Implications  
Approval for this scholarly project was received from the Institutional review 
board (IRB) committee at Walden University (Approval No. 10-24-17-0425539)  and the 
Nephrology practice office.  The measurements and laboratory results for creatinine, 
estimated glomerular filtration rate (eGFR), microalbumin, mean arterial pressure (map) 
and hemoglobin A1C which were routinely obtained at first CKD office visit was treated 
as baseline and entered SPSS statistical program. Subsequent data collected from six 
months and one-year visits were added into the program. The analysis of data was 
completed using the SPSS 21.0 for Windows 7 (SPSS Inc. Chicago, IL, USA).  
Descriptive statistics and relationship of the characteristics were analyzed using the group 
mean and standard deviation for participants in the CKD class and non-participants.  . 
A total of 322 patients with CKD III and IV were identified as admitted to the 
nephrology practice from January 2014 to December 2015. Of this group, fifty-two 
(n=52) patients fitted the criteria of CKD stages III and IV with hypertension and/or 
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diabetes. Twelve (n=12) CKD stage III and IV patients out of the 52 (23.1%) were 
identified as did not attend the NNP led CKD class and are designated as ‘Parti-n’ for 
analysis, while the remainder 40 CKD patients (76.9%) who attended the nurse 
practitioner led CKD education class were designated as ‘Parti-y’. (see table 1) 






Percent Valid Percent Cumulative 
Percent 
Valid 
n 12 23.1 23.1 23.1 
y 40 76.9 76.9 100.0 
Total 52 100.0 100.0  
 
 
The mean creatinine at admission for Parti-n group was 2.5583 mg/dl and at one-
year visit was 2.7417mg/dl – an increase of 0.1834mg/dl or 7% and a standard deviation 
of 0.80829. In contrast, the mean creatinine of the Parti-y group on admission was 2.8025 
mg/dl. At the end of one year, the mean creatinine in this group was 1.9550mg/dl – a 
decrease of 0.8475 mg/dl or 30.2% and a standard deviation of 0.37168 (see Table 2). 
Table 2.  
Group statistics 
Group Statistics 
 parti N Mean Std. Deviation Std. Error Mean 
creat1 
n 12 2.5583 .78214 .22578 




n 12 2.8333 .80829 .23333 
y 40 1.9075 .37168 .05877 
 
There was a concomitant decrease in eGFR in the Parti-n group from 25.5833 
mL/min/1.73m2   to 24.4167 mL/min/1.73m2. This contrasts with a rise in eGFR in the 
Parti-y group from 24.0962 mL/min/1.73m2   to 33.4250 mL/min/1.73m2.  (see Table 3). 
The difference is better illustrated by a bar chart in Appendix E 
Table 3.  
Report 
Mean   
parti creat1 creat3 hga1c1 hga1c3 egfr1 egfr3 
n 2.5583 2.7417 6.9571 8.1000 25.5833 24.4167 
y 2.8025 1.9550 4.8727 4.1455 23.6500 33.4250 
Total 2.7462 2.1365 5.2375 4.8375 24.0962 31.3462 
 
Patients in the Parti -y group had an eGFR increase by about 32%, (p<0.05) while 
the patients in the Parti-n group had an eGFR reduction of 11%. Across the board, there 
was a marked decrease in mean arterial pressure in Parti-y group than in Parti-n group. 
Same results were noted with microalbumin and hemoglobin A1c levels. (See figure 1 in 
Appendix B) 
In the diabetic patients, the significant measures of control were the hemoglobin 
A1c and microalbumin. Results from data collected of the Albumin and hgbA1c reflect a 
decrease in both hgbA1c and albumin in the Parti-y group. The mean hgbA1c in the 
Parti-n group rose from 6.9571 to 8.1000 over a 1-year period. In contrast, the mean 
hgA1c in the Parti-y group decreased from 4.8727 to 4.1455 over the same period (see 
Appendix D).  
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This same pattern was observed in measured mean albumin over one year in the 
two groups with decreasing microalbumin in the participating group and an increase in 
mean microalbumin in the non-participating group suggesting worsening renal function. 
A bar chart comparison further illustrates this observed pattern. (See Appendix C). 
A significant finding was the relatively large standard deviation of mean arterial 
pressure in Parti-n that ranged from group mean of 9.243 at first visit reading to 17.113 at 
1-year mark reading. This indicates a large amount of variation in the group that is 
affected by outliers. In contrast, Parti-y had a small mean standard deviation from 14.373 




parti egfr1 egfr3 alb1 alb3 creat1 creat3 map1 map3 hga1c1 hga1c3  
n 
Mean 
25.5833 24.4167 363.1429 541.1429 2.5583 2.7417 99.5000 108.0000 6.9571 8.1000 
 
Std. Deviation 




23.6500 33.4250 283.3333 109.3939 2.8025 1.9550 104.0294 85.8788 4.8727 4.1455 
 
Std. Deviation 




24.0962 31.3462 297.3000 184.9500 2.7462 2.1365 103.1667 90.1951 5.2375 4.8375 
 




The results of this evaluation of a quality improvement program using the case 
control method with retrospective secondary data collected from the nephrology practice 
patient health record suggests that participation in a NNP led CKD class in addition to 
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education by nephrologists during a routine office visit could effectively lead to decrease 
in progression of CKD disease as evidenced by decreased mean serum creatinine levels, 
microalbumin, mean arterial pressures, hemoglobin A1c and a rise in eGFR in the group 
that participated. A principal finding in this evaluation is that more information and 
knowledge about self-management of CKD seems to be a key factor in slowing the 
progression of disease. Further studies could eventually reveal the actual roles played by 
the individual patients that contributed to the improvement of renal functions. The CKD 
education classes focused on understanding CKD disease process, strict diabetes and 
blood pressure monitoring and management (BP and RAAS interruption) (Glycemic 
Control), salt restriction, medication adherence, dietary and lifestyle changes - exercise 
and weight loss, smoking cessation and planning for the future – treatment options for 
dialysis/transplantation.  
Patients who participated in the CKD class seem to be better equipped to achieve 
a better control of their blood glucose and blood pressures, better adherence to 
medications, strict diet restrictions and weight loss programs. It seems that these core 
lifestyle changes may have played a role in the observed improvement in the clinical 
measurement outcomes of improving renal functions as evidenced by better serum 
creatinine levels and eGFR. Patient participation in their care essentially helps to improve 
relations with clinicians and patients leading to a situation where patient will embrace 
CKD treatment to maximize positive outcomes (Sue-Hsien et al,, 2011).  These results 
suggest that multidisciplinary care and reinforcement of information is very important 
and effective in halting the progression of CKD disease. This study echoes recent studies 
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that confirm the significant role of CKD education and knowledge in delaying 
progression of CKD disease. The role of the NNP cannot be underestimated as improving 
patient outcomes benefits from team efforts in a multidisciplinary setting. It can be 
surmised that patient’s interaction with the nurse practitioner in this setting leads to 
improved overall outcome. 
Recommendations 
A known fact is that with or without care – CKD progresses and with close and 
good management, the rapidity of this process could be delayed.  In this evaluation of a 
quality improvement program in a nephrology practice in Dayton Ohio, the guiding 
practice focused question has been “ what is the impact of a NNP led CKD education 
class on preventing disease progression advanced CKD patients with diabetes and/or 
hypertension? The CKD education focuses on the ever-changing role of patients in 
managing symptoms, disability and outcomes that will impact disease management 
(Corbin & Strauss, 1991) while stressing active patient participation in monitoring of risk 
factors for CKD like hypertension, diabetes and proteinuria - an identified gap in 
practice.  
Slowing down the progression rate of CKD disease will help reduce the 
devastating outcomes of end stage renal disease and help reduce mortality and morbidity 
with this disease. Financially, it will reduce societal costs to treating ESRD estimated at 
about $42 billion with $34 billion absorbed through Medicare budget (U.S. Renal Data 
System, 2013). While the project focused on evaluating the outcome of CKD education, 
the intended inference to be drawn centered on the involvement of the NNP in the 
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management of CKD disease. The NNP’s contribution to the management of CKD will 
bring about a significant shift and social change in what is the norm of nephrology 
practice (Mack. et.al, 2010). Among the competencies identified by ANNA, the 
nephrology APN can independently assess, conceptualize and diagnose complex health 
problems; manage acute and chronic renal disease in a variety of healthcare settings; 
prescribe, administer, and evaluate pharmacologic and therapeutic treatment regimens 
while being able to identify, study, and solve complex problems in the areas of 
nephrology (Counts, 2008).  
A recommended solution that will potentially address this gap-in-practice as 
informed by the findings discussed above will be developing and implementing protocols 
that will mandate NNP involvement in CKD management in all States of the Union. 
Organizations like ANNA and the ANA need to strongly voice their opinions and come 
up with a nephrology nurse practitioner pathway in the NP programs that will guarantee 
the training of nurse practitioners in the nephrology sub-specialty. There is a need to 
develop guidelines that will broaden the scope of practice of the NNP and compensate 
them accordingly as in other specialties.  
It may seem like an over reach but mandating CKD education for all patients by 
healthcare policy makers will eventually benefit the patients, insurance companies and 
payors like Medicare and Medicaid. The gains of involving an NNP in the care 
continuum of CKD management can not be overemphasized. Final recommendations will 
be made to the nephrology practice where the scholarly project was conducted. 
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Contribution of the Doctoral Project Team 
In this study, the team consisted of the Project Chair and committee members, the 
URR, the investigator and the medical assistants at the nephrology practice. I was the 
principal investigator and my role included identifying the project, engaging and 
recruiting medical assistants that collected the data from the electronic health records, 
developing and identifying patients that met the criteria for inclusion and exclusion from 
the project,  setting measurable objectives for the project, identifying the gap-in-practice, 
defining the problem, participating in the actual CKD education class, collecting data 
needed for evaluating the project performance and producing a written report on the 
findings. As a DNP student undergoing the practicum project in a nephrology group 
setting, I had the opportunity of participating in the CKD education class for patients with 
stage III and IV who have both diabetes and hypertension and as such it was a great 
setting to evaluate the impact of the CKD class on disease progression 
Strengths and Limitations of the Project 
This project is limited by its sample size of 52 patients and duration of 1 year 
follow up. Consideration was not given to other variables such as the level of education, 
age, co-morbidities, economic/financial status, sex, religious affiliation, lifestyle, and 
insurance coverage. Another limitation was that I was not able to identify the specific 
behavioral changes or individual self-management skills that contributed to the 
improvement of renal function for the participating patient group due to the retrospective 
project design and time constraints.  It is my belief that given the significant association 
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between participating in CKD education and slowing the progression of CKD, a larger 
population study over a period may produce same results. 
Summary 
          This project evaluated a nurse practitioner led CKD education class - a quality 
improvement program in a nephrology practice in Dayton Ohio by examining the impact 
on disease progression as evidenced by stable or improved serum creatinine (Scr), 
estimated glomerular filtration rate(eGFR), mean arterial pressure (MAP), 
microalbumin(Alb) and hemoglobin A1C(hgbA1c) levels using the case control research 
method with retrospective secondary data. There was a significant finding of group mean 
improved renal function across board in the case group who received routine office visit 
instructions and participated in the nephrology nurse practitioner led CKD education 






Section 5: Dissemination Plan 
Introduction 
With broad goals of increasing the reach of evidence to increase people’s 
motivation and ability to use and apply evidence, dissemination is the targeted 
distribution of information and intervention materials to a specific public health or 
clinical practice audience aimed at spreading knowledge (Glasgow et al., 2012). 
Dissemination strategies aim to spread knowledge and the associated evidence based 
interventions on a wide scale within and across geographical locations, practice settings, 
social or other networks of end users such as patients and health care providers. An 
excellent example that I feel is a great dissemination tool for this project is a policy brief. 
Policy briefs are short documents that present the findings and recommendations of a 
research project to both a specialized and non-specialized audience. It is usually a stand-
alone document, focused on a single topic and no more than 2–4 pages (~1500 words). 
Jones and Walsh (2008) have observed that when policy briefs are carefully designed, 
they can be a powerful tool for communicating research findings to development policy 
audiences since policy-makers are constrained by time and overwhelmed by various 
sources of information, they are likely to make quick decision by selecting the evidence 
most appropriate to their political leanings. It is usually limited to a problem at hand, 
promotional and understandable in clear concise language focused on achieving the 
intended goal of convincing the target audience (Young & Quinn, 2002). 
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Analysis of Self 
          My role is that of a scholar-practitioner who is in the process of mastering an 
academic discipline and practicing a profession.  As a scholar-practitioner, I desire to 
learn while actively engaging in my profession – Nursing. While studying with my 
preceptor in my role as a Doctor of Nursing Practice student and principal investigator, I 
took time to reflect on available data and feedback about my profession, best practices, 
beliefs and have formed a vision of my future professional role after spending time in 
collaborative conversations with my preceptor. My experience with this study and the 
results convince me that APNs have a great wealth of knowledge to offer in the 
management of CKD and other chronic illnesses. Insights gained from this experience 
include the need to develop curricular for specialties like the NNP in the State of Ohio to 
cultivate the work force for this role as obtain in some states. The role of the APN –NNP 
in managing CKD needs to be escalated from dialysis rounds to intense follow up for 
CKD early stages. This will in turn reduce the waiting time for referrals and follow ups of 
new and old patients with CKD disease.  The present state of using APNs in the 
employment of nephrology groups for hospital rounds as scribes and dialysis rounds is 
obsolete. As a long term professional goal for me, I plan to work closely with the ANNA 
and American Nurses Association (ANA) to continue to develop a pathway for an APN 
specialty in nephrology by taking ideas from the critical care model that is conducting 
residency program for APNs in critical care services. 
Establishing a family practice center within the inner city limits is another 
professional goal. Walden’s social change drive has been an important guide for my 
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academic endeavor to be competent in my abilities to provide comprehensive care of 
patients with a broad range of medical conditions across the spectrum of acute illness in 
an office setting by applying evidence based, cost conscious strategies to diagnosis and 
disease management in patients in the clinic setting. I will strive to transfer knowledge 
acquired during the long Practicum experience into practice by continuing to precept 
novice APNs in this clinic in a city that lacks enough preceptors for family practice 
practitioners. 
Summary 
          CKD is a devastating diagnosis for any patient. With and without close monitoring, 
CKD progresses to ESRD. A CKD education program with emphasis on strict blood 
pressure and blood glucose control, diet and exercise, medication adherence, lifestyle 
changes and smoking cessation was found to have a positive effect in delaying the 
progress of CKD in patients who participated in the process. The rate of disease 
progression and associated co-morbidities can be delayed or reversed as evidenced by the 
above scholarly project. Evidence strongly suggest that participation in a NNP directed 
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Appendix A. Stages of CKD 
 
 
Source: National kidney Foundation. (2015). People like us - About chronic kidney 






Appendix B.  













Appendix D. Table 3 report 
 
Mean   
parti creat1 creat3 hga1c1 hga1c3 egfr1 egfr3 
n 2.5583 2.7417 6.9571 8.1000 25.5833 24.4167 
y 2.8025 1.9550 4.8727 4.1455 23.6500 33.4250 












Appendix F. Table 4 general report 
 
 
parti egfr1 egfr3 alb1 alb3 creat1 creat3 map1 map3 hga1c1 hga1c3  
n 
Mean 
25.5833 24.4167 363.1429 541.1429 2.5583 2.7417 99.5000 108.0000 6.9571 8.1000 
 
Std. Deviation 




23.6500 33.4250 283.3333 109.3939 2.8025 1.9550 104.0294 85.8788 4.8727 4.1455 
 
Std. Deviation 




24.0962 31.3462 297.3000 184.9500 2.7462 2.1365 103.1667 90.1951 5.2375 4.8375 
 




Appendix G. CKD Education Guideline  
Objective: Educate the CKD patient and family on disease process, coping mechanisms, 




• Chronic kidney disease – what you need to know 
1. Anatomy of the kidney 
2. Function 
3. CKD – diagnosis, causes, stages, symptoms  
4. Understanding the complications 
5. Meaning of laboratory results – Creatinine, BUN, Phosphorous, 
Potassium, Sodium, Albumin, hemoglobin, hematocrit, platelets and 
hemoglobin A1c 
6. Finance 
7. CKD care team – Dietician, social worker, nephrologist, nurse practitioner 
• Chronic kidney disease – Effects on the patient 
1. Heart and blood vessels  
2. Anemia 




• Chronic kidney disease – Plan of care 
1. Blood pressure management 
2. Diabetes management 
3. Cholesterol management 
4. Treating Anemia 
5. Lowering risk of bone disorders 
6. Preserving renal function 
7. Managing depression 
8. Eating healthy 
9. Exercise 
• Chronic kidney disease – Treatment options 
1. Kidney transplantation 
2. Hemodialysis 
3. Peritoneal dialysis 
4. Choosing no treatment 
• CKD – Choosing transplantation 
1. Understanding kidney transplantation – how it works 
2. Donors – Living, cadaver, paired exchange, Altruistic 
3. Matching and compatibility 
4. Immunosuppression and rejection 
68 
 
5. Living well with a transplant 
• CKD – Choosing the type (Hemodialysis vs. Peritoneal dialysis) 
1. How dialysis works 
2. Accesses 
3. Equipment 
4. Home vs in-center options 
5. Travelling and working while on dialysis 
6. Nutrition 
7. Pros and cons 
• CKD – Living well with your choices 
1. Psychosocial issues and well being 




                                                                    (Source: National Kidney Foundation) 
 
 
 
